Skip to content
Disclosery

Lunate Capital Ltd

Follow

13F filer, CIK 2056786, AL MARYAH ISLAND, ABU DHABI, United Arab Emirates

Lunate Capital Ltd reported $171,209,775 across 4 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-04-25.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001011438-25-000228

Period
2025-03-31
Reported value
$171M
Holdings
4
Top 10 weight
100%
New
Sold out

Part of the filer group Lunate Capital Ltd

How groups are built

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001011438-25-000228, largest first. % of portfolio is the value over $171,209,775, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,196,200 shares 2,196,200$77.7M45.36%Timeline
SAILSAILPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 3,000,000 shares 3,000,000$56.2M32.85%Timeline
LINELINEAGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 600,000 shares 600,000$35.2M20.55%Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,124,143 shares 2,124,143$2.12M1.24%Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001011438-25-000228 base2025-04-25acceptance time not in the bulk data set